about
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitisShort-course oral steroids alone for chronic rhinosinusitisSaline irrigation for chronic rhinosinusitisSystemic and topical antibiotics for chronic rhinosinusitisDifferent types of intranasal steroids for chronic rhinosinusitisShort-course oral steroids as an adjunct therapy for chronic rhinosinusitisShort-course oral steroids as an adjunct therapy for chronic rhinosinusitisThe burden of revision sinonasal surgery in the UK-data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study.Paediatric retropharyngeal abscess.A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post-operative symptoms.Cochrane Corner: Extracts from The Cochrane Library.Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?Bronchiectasis and sino-nasal disease: a review.A brief history of olfaction and olfactometry.Function or cosmesis--what is the predominant concern in patients with nasal trauma presenting for rhinoplasty?ENT cases seen at a local 'walk-in centre': a one year review.Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors.Tumefactive fibroinflammatory lesion of the frontal sinus.Endoscopic frontal sinusotomy-preventing recurrence or a route to revision?Endoscopic management of inverted papillomas: long-term results--the St. Paul's Sinus Centre experience.Nanomedicine in otorhinolaryngology: what does the future hold?Pathogen yield and antimicrobial resistance patterns of chronic rhinosinusitis patients presenting to a tertiary rhinology centre.Selecting the best approach to the frontal sinus.Assessing the sense of smell.Hyposmia.The impact of commissioning for rhinosinusitis in England.Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners.Quality-of-life outcomes after sinus surgery in allergic fungal rhinosinusitis versus nonfungal chronic rhinosinusitis.Health utility reporting in chronic rhinosinusitis patients.The genetics of cholesteatoma. A systematic review using narrative synthesis.The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis.SNOT-22 in a control population.A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes.Position paper on olfactory dysfunction.EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis.Chronic rhinosinusitis and mood disturbance.A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders.Unilateral cacosmia: a presentation of maxillary fungal infestation.Intranasal sodium citrate solution improves olfaction in post-viral hyposmia.Timing of tracheostomy in adult patients: potential ramifications are alarming.
P50
Q24185859-02D84835-D50D-420D-93BD-268E2F0675C1Q24185860-910744AD-017C-4936-8287-C7F8BF52C836Q24185862-810E55FB-4732-49EC-A5C9-62CD2881A8D4Q24185864-BF280F9B-7924-4442-8C58-8CD535739DADQ24185865-E8AF3FBB-86BC-4DF3-BC88-DBB4D5BDE55DQ24185867-2E197320-6FE2-4A24-AC6B-E2DEDC606E86Q24187421-0982423E-E99D-4EFC-A93B-A701204743FBQ30940921-9236C738-4568-4684-8EA8-9599A5A86D47Q31143274-7BF0A905-1EEC-4C63-A82D-90AED7351F33Q33214203-7D3A750F-1083-43E7-901A-FA75D968F8B1Q36293735-884DFFDB-E2B0-4991-8C20-8F6C002B3AECQ36623337-5DF4F84F-7703-496C-AD57-A59C988F0D60Q36860653-F944A400-E305-41A2-95CA-00EF2D1D6643Q37059189-F88E8F88-B2CE-481F-AFFA-458C10100741Q37118670-CC005643-048D-49E3-AB9B-570914784441Q37165734-1A67480E-932C-4C92-AB71-090D8B8BAFAAQ37593082-B4CF69AE-3CC8-4C29-AD29-7BE64187EA84Q37763311-8A12F9D8-1C0B-44AC-B407-F54B81794D79Q37766814-F64B9FE6-56AA-4DF2-BC69-0F40030C0FACQ37805355-DB6AB135-6A48-4DC0-B775-B6986E00ECF0Q37813038-B45FF66C-9957-4190-AE83-5BB37EBF6613Q37868815-917FEE9F-BA26-4793-B698-654505500F5FQ37982728-E2BF0D2A-1D7D-4C1B-87FD-41A4497AC322Q38374246-5E26461C-B6B8-4B52-871B-765014612D96Q38374248-22C9313B-10C3-49E7-B7C1-79A7FB47F48CQ38410242-6ED7376A-FBC1-4EA9-BB04-9FC8D113E313Q38633715-94778BE9-54A3-4911-814B-8F4E7C9DAD95Q38776068-01F0B889-4240-4676-92E8-F7CEC23E7263Q38789370-47407C8E-F87F-4BB7-B583-61311CD08220Q38796530-C400684A-8535-4BF2-8536-77558B13BD48Q38862694-3865A36F-1239-4DF1-96A8-202785DDEA94Q38871388-8DEB44AF-1133-41E4-BACB-2852FF6ECAC5Q39674760-CF9E8C7C-F930-4EE8-A052-41D45F03716AQ40156479-BE9FDCC1-B18D-4E47-91E1-D694732575EAQ40202376-B0A0DE4F-7687-4ACD-9DCC-D112424B9C62Q40231510-F201788D-7578-44F5-9FE3-2286C2212B73Q40275662-19ECCCA6-E891-4D92-A1EB-5E3B1CA910C4Q40446273-B3EFB502-9A64-49A6-A14B-7421A9897926Q40694758-23103BBF-BC76-4F2A-B815-B8F8B99CC24BQ42933391-8399DD4C-45C2-440E-8200-6E0D2571AB97
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carl M Philpott
@nl
Carl M Philpott
@sl
Carl M. Philpott
@en
Carl M. Philpott
@es
type
label
Carl M Philpott
@nl
Carl M Philpott
@sl
Carl M. Philpott
@en
Carl M. Philpott
@es
prefLabel
Carl M Philpott
@nl
Carl M Philpott
@sl
Carl M. Philpott
@en
Carl M. Philpott
@es
P106
P1153
54973914300
P21
P31
P496
0000-0002-1125-3236